DOWNLOAD THE AGENDA:
6th Annual Regulatory Operations and Submissions Conference

May 22-23, 2017 | Philadelphia, PA

Wyndham Philadelphia Historic District

Please Complete Form to Download Your Agenda

ABOUT THE CONFERENCE

Q1 has over a dozen years of experience in providing high level educational content for the regulatory operations professional in the life science industry and is consistently ranked by participants as delivering quality program content, speaker selection, and facilitation.

This program is unique in that explores the future of the eCTD while offering process optimization best practices for current submission formats. All content is delivered by industry speakers as case studies, panels, and traditional presentations so you will return to the office with tangible ideas that may be implemented immediately.

The program has been designed to deliver on three core pillars of educational excellence:

1. Peer-led case studies and master classes- Industry leaders from organizations such as Karyopharm Therapeutics, Medimmune, and Pfizer will lead solution driven, in-depth discussions about common industry challenges. You will come back to the office with a better understanding of how other companies are successfully accomplishing regulatory process optimization.

2. Professional development opportunities- Attendees will participate in both small and large group discussions as well as live polling to incorporate attendee experience and expert information. The program draws a high-level audience, so the expertise gained from the other attendees will be as valuable as the presenters.

3. Structured networking- Throughout the two days, there are multiple peer-to-peer networking opportunities which will assist in building our mutual network. Coffee breaks and luncheons facilitated each day will enable attendees to continue operation innovation and optimization-focused discussions.

Download the agenda to see all the presentation topics, speakers and formats.

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED